综述:在终末期肝病中追求生命数量的同时最大化生活质量
本综述通过检索PubMed和Web of Science,汇总干预研究对终末期肝病患者健康相关生活质量的影响。研究表明管理营养不良、肝性脑病和腹水可显著改善健康相关生活质量,早期引入姑息治疗可改善临终关怀质量。
要点
- 管理营养不良、肝性脑病和腹水可显著改善终末期肝病患者的健康相关生活质量。
- 早期识别和管理这些并发症是更好服务患者的关键。
- 早期引入姑息治疗可改善临终关怀质量。
核心结论
- 肝硬化并发症包括营养不良、脑病、腹水和静脉曲张出血导致健康相关生活质量下降。
- 健康相关生活质量的评估对患者具有重要含义。
- 本综述 findings 阐明使用一致工具准确评估终末期肝病患者生活质量的重要性。
研究设计与样本
- 文献综述,检索PubMed和Web of Science,以「生活质量」「肝硬化」「终末期肝病」作为MeSH词或标题检索词。
主要发现
- 这些研究一致显示,管理营养不良、肝性脑病和腹水可显著改善健康相关生活质量。
- 早期引入姑息治疗可改善临终关怀质量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With recent advances in the management of chronic liver disease and its complications, the long-term survival in cirrhosis has improved. Therefore, the number of individuals who will spend a significant proportion of their life with end-stage liver disease (ESLD) may continue to rise. Thus, more attention to quality of life (QOL) and its integration with traditional clinical endpoints is needed. AIMS: Recently, there have been many studies looking at treatment outcomes and their impact on the QOL in patients with ESLD. The aim of this review was to summarise and compare the insights gained from these intervention studies and to make concise recommendations to further promote and improve QOL in this patient population. METHODS: A literature search was conducted using PubMed and Web of Science. Search terms "Quality of life" "Cirrhosis" and "end-stage liver disease" were used as MeSH terms or searched in the title of the article. RESULTS: These studies uniformly show significant improvement in health-related QOL (HRQOL) with management of malnutrition, hepatic encephalopathy and ascites. Thus, early recognition and management of these complications are keys to better serve our patients. Early involvement of palliative care also leads to improved quality of end-of-life care. CONCLUSIONS: Complications of cirrhosis including malnutrition, encephalopathy, ascites and variceal bleeding lead to a decrease in HRQOL. Assessment of HRQOL has an important implication for the patient. The findings of this review illuminate the importance of using consistent tools to accurately assess QOL in patients with ESLD.
引用
- Bhanji RA, Carey EJ, Watt KD, et al. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017. PMID: 28464346. doi:10.1111/apt.14078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。